2016. EULAR Annual Congress – Cost per Response for Abatacept Compared with Adalimumab in the Treatment of Patients with Rheumatoid Arthritis Based on Anti-Citrullinated Protein Antibody Titres in Italy, Spain and Canada

Foo J, Mennini F, Rodriguez Heredia JM, Choquette D, Attina G, Jiménez Merino S, Mtibaa M, Alemao E, Gaultney J. Cost per Response for Abatacept Compared with Adalimumab in the Treatment of Patients with Rheumatoid Arthritis Based on Anti-Citrullinated Protein Antibody Titres in Italy, Spain and Canada. Ann Rheum Dis. 2016;75(Suppl2):415. Presented at: EULAR 2016; June 8-11, 2016; London, UK.